Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mismatch type impacts interference and priming activities in the type I-E CRISPR-Cas system.

The Journal of biological chemistry·2026
Same author

Mismatch type impacts interference and priming activities in the type I-E CRISPR-Cas system.

bioRxiv : the preprint server for biology·2026
Same author

FucR Functions as a Transcriptional Regulator for L-Fucose Utilization in <i>Campylobacter jejuni</i>.

Microorganisms·2025
Same author

Plant Defense Proteins: Recent Discoveries and Applications.

Plants (Basel, Switzerland)·2025
Same author

CRISPR2025 New Zealand: Innovation and Collaboration.

The CRISPR journal·2025
Same author

Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications.

Molecules (Basel, Switzerland)·2023
Same journal

RETRACTED: Sobeh et al. A Polyphenol-Rich Fraction from <i>Eugenia uniflora</i> Exhibits Antioxidant and Hepatoprotective Activities In Vivo. <i>Pharmaceuticals</i> 2020, <i>13</i>, 84.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Correction: Jiménez-Sánchez et al. Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs. <i>Pharmaceuticals</i> 2026, <i>19</i>, 522.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Correction: Zhao et al. Multifunctional Gel Films of Marine Polysaccharides Cross-Linked with Poly-Metal Ions for Wound Healing. <i>Pharmaceuticals</i> 2022, <i>15</i>, 750.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Intravenous Immunoglobulin Reveals a Novel Protective Mechanism: Targeting the GBP5-Driven Pyroptosis Axis in Experimental Colitis.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Icariin Attenuates Renal Injury in Streptozotocin-Induced Diabetic Rats with and Without Adenine-Induced Chronic Kidney Disease.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

AI-Assisted Identification of a Putative Allosteric Ligand Targeting the CDK4/Cyclin D1 Protein-Protein Interface.

Pharmaceuticals (Basel, Switzerland)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 8, 2025

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.8K

Aptamer Applications in Neuroscience.

Meric Ozturk1,2, Marit Nilsen-Hamilton1,3,4, Muslum Ilgu1,2,3,4

  • 1Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011, USA.

Pharmaceuticals (Basel, Switzerland)
|December 28, 2021
PubMed
Summary
This summary is machine-generated.

Aptamers show promise for diagnosing and treating neurological disorders, which affect over a billion people globally. These nucleic acid therapies offer new hope for conditions like Alzheimer's and Parkinson's disease.

Keywords:
aptamercancerneurological diseasesneurological disordersneuroscienceneurotoxins

More Related Videos

Selection of Aptamers for Amyloid &#946;-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.6K
Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis
08:09

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis

Published on: January 7, 2017

10.8K

Related Experiment Videos

Last Updated: Oct 8, 2025

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.8K
Selection of Aptamers for Amyloid &#946;-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.6K
Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis
08:09

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis

Published on: January 7, 2017

10.8K

Area of Science:

  • Biotechnology
  • Neuroscience
  • Molecular Biology

Background:

  • Neurological diseases are a leading cause of disability worldwide.
  • Over a billion individuals suffer from conditions such as dementia, epilepsy, stroke, and neurodegenerative diseases.
  • Current diagnostic and treatment options for many neurological disorders are limited.

Purpose of the Study:

  • To review the pioneering applications of aptamers in the field of neurology.
  • To highlight the potential of aptamers for diagnosing and treating neurological disorders.
  • To discuss the promise of aptamers in addressing global health challenges posed by neurological diseases.

Main Methods:

  • Literature review of studies on aptamer applications in neurological disorders.
  • Analysis of aptamer characteristics, including size, non-immunogenicity, and chemical modifiability.
  • Synthesis of findings on aptamer-based diagnostics and theranostics for neurological conditions.

Main Results:

  • Aptamers are small, non-immunogenic nucleic acid molecules with potential for easy chemical modification.
  • Pioneering studies demonstrate aptamers' promise in the diagnosis and treatment of various neurological diseases.
  • Aptamers offer a potential new avenue for addressing unmet needs in neurological disorder management.

Conclusions:

  • Aptamers represent a promising technology for the future of neurological disorder diagnostics and therapeutics.
  • Further research and development in aptamer applications could significantly impact global health outcomes for neurological conditions.
  • The unique properties of aptamers make them valuable tools for tackling complex neurological health challenges.